
New mechanism of anti-tumour action identified
In an article published in Clinical Cancer Research, researchers from INc-UAB and Ability Pharmaceuticals describe a new mechanism of anti-tumour action, discovered during the development of the drug ABTL0812 – currently being tested in patients with advanced cancer.